Quantcast
Last updated on April 23, 2014 at 15:23 EDT

Latest Prospectus Stories

2014-04-11 08:24:33

BASKING RIDGE, N.J., April 11, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), today announced the pricing of its previously announced underwritten public offering of 10,000,000 shares of its common stock, offered at a price of $6.00 per share to the public. The gross proceeds to Regado from this offering are expected to be approximately $60.0 million, before deducting underwriting discounts and commissions, and other estimated offering expenses payable by Regado. The...

2014-04-10 16:23:13

CARLSBAD, Calif., April 10, 2014 /PRNewswire/ -- NTN Buzztime, Inc. (NYSE MKT: NTN) today announced that it intends to offer shares of its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. http://photos.prnewswire.com/prnvar/20120117/LA36540LOGO Roth Capital Partners is serving as the sole...

2014-04-10 08:31:37

ATHENS, Greece, April 10, 2014 /PRNewswire/ -- Box Ships Inc. (NYSE:TEU) (the "Company") today announced that it has priced its public offering of 5,000,000 units consisting of its common shares and warrants at $2.05 per unit. Each unit consists of one common share and a warrant to purchase 0.40 common shares. The warrants have an exercise price of $2.65 per share, are exercisable immediately, and will expire on April 10, 2019. In addition, the Company has the right, commencing...

2014-04-10 08:30:21

Funding Will Accelerate Expansion of European Manufacturing BETHESDA, Md., April 10, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that on April 9, 2014, it entered into an agreement with a single institutional investor for a registered direct placement of up to $32 million. The Stock Purchase Agreement provides for the sale of an initial $15...

2014-04-09 20:22:09

EMERYVILLE, Calif., April 9, 2014 /PRNewswire/ -- Adamas Pharmaceuticals, Inc. (Adamas), a specialty pharmaceutical company, today announced the pricing of its initial public offering of 3,000,000 shares of its common stock at a public offering price of $16.00 per share, before underwriting discounts and commissions. The shares are expected to begin trading on The NASDAQ Global Market under the ticker symbol "ADMS" on April 10, 2014. In addition, Adamas has granted the underwriters a...

2014-04-09 20:20:06

DETROIT, April 9, 2014 /PRNewswire/ -- Ally Financial Inc. (Ally) today announced the pricing of its initial public offering of 95,000,000 shares of common stock at a price to the public of $25 per share. The underwriters of the offering will have a 30-day option to purchase up to an additional 14,250,000 shares of common stock from the U.S. Department of the Treasury (Treasury) at the initial public offering price. Ally's common stock is expected to begin trading on the New York...

2014-04-09 16:24:42

ORLANDO, Fla., April 9, 2014 /PRNewswire/ -- SeaWorld Entertainment, Inc. ("SeaWorld Entertainment" or the "Company") today announced the closing of the previously announced underwritten secondary offering (the "Offering") by the selling stockholders (the "Selling Stockholders") affiliated with The Blackstone Group L.P. of 17,250,000 shares of common stock of the Company, including 2,250,000 shares that were offered and sold by the Selling Stockholders pursuant to the full exercise of...

2014-04-09 16:22:01

ATHENS, Greece, April 9, 2014 /PRNewswire/ -- Box Ships Inc. (NYSE:TEU) (the "Company") today announced that it has commenced an underwritten offering of units consisting of its common shares and warrants. The Company intends to grant the underwriters of the offering a 45-day option to purchase an additional 15% of the units sold in the offering to cover over-allotments, if any. In the event that at least $10.0 million of units are sold in the public offering, Neige International...

2014-04-08 16:23:30

CASTLE ROCK, Colo., April 8, 2014 /PRNewswire/ -- Venaxis, Inc. (NASDAQ:APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1(TM) Test, a rapid, multiple biomarker-based index assay for identifying patients that are at low risk for appendicitis, today announced the closing of its previously announced underwritten public offering of 8,335,000 shares of its common stock at a price to the public of $2.40 per share. In...

2014-04-08 16:23:29

SAN FRANCISCO, April 8, 2014 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced the closing of its public offering of 3,450,000 shares of its common stock, including 450,000 shares sold pursuant to the exercise in full by the underwriters of their over-allotment option, at a public offering price of $18.00 per share. Kindred Bio estimates net proceeds from the offering to be...